99 related articles for article (PubMed ID: 6217001)
1. Anti-thyroid drugs and lymphocyte function. II. The in vivo effect on blastogenesis and suppressor cell activity in Graves' disease.
Goldrath N; Shoham J; Bank H; Eisenstein Z
Clin Exp Immunol; 1982 Oct; 50(1):62-9. PubMed ID: 6217001
[TBL] [Abstract][Full Text] [Related]
2. Anti-thyroid drugs and lymphocyte function. I. The in vitro effect on blastogenesis and suppressor cell activity.
Goldrath N; Eisenstein Z; Bank H; Shoham J
Clin Exp Immunol; 1982 Oct; 50(1):55-61. PubMed ID: 6217000
[TBL] [Abstract][Full Text] [Related]
3. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.
Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I
N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953
[TBL] [Abstract][Full Text] [Related]
4. Effects of antithyroid drugs on Con A-induced suppressor cell activity.
Okabe N; Mori R; Miake S; Inoue K
J Clin Lab Immunol; 1984 Apr; 13(4):167-9. PubMed ID: 6234399
[TBL] [Abstract][Full Text] [Related]
5. Effects of antithyroid drugs on lymphocyte proliferative responses to lectins: relationship between insulin autoimmune syndrome and methimazole.
Okabe N; Inoue K; Mori R
J Clin Lab Immunol; 1983 Aug; 11(4):167-71. PubMed ID: 6689431
[TBL] [Abstract][Full Text] [Related]
6. Decrease of concanavalin-A activated and short lived suppressor T cell function in thyrotoxicosis.
Balázs C; Leövey A; Bordan L
Biomedicine; 1979 Jul; 30(3):143-7. PubMed ID: 158395
[TBL] [Abstract][Full Text] [Related]
7. Influence of propylthiouracil and methimazole pre-treatment on the outcome of iodine-131 therapy in hyperthyroid patients with Graves' disease.
Shi GM; Xu Q; Zhu CY; Yang YL
J Int Med Res; 2009; 37(2):576-82. PubMed ID: 19383254
[TBL] [Abstract][Full Text] [Related]
8. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy.
Chattaway JM; Klepser TB
Ann Pharmacother; 2007 Jun; 41(6):1018-22. PubMed ID: 17504839
[TBL] [Abstract][Full Text] [Related]
9. Methimazole treatment in Graves' disease: behaviour of CD5+B lymphocytes and regulatory T cell subsets.
Paggi A; Amoroso A; Ferri GM; Mariotti A; Pellegrino C; Afeltra A
Eur Rev Med Pharmacol Sci; 1998; 2(1):11-9. PubMed ID: 9825565
[TBL] [Abstract][Full Text] [Related]
10. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of methimazole on dendritic cell (DC) function and DC-induced Graves' hyperthyroidism in mice.
Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
Autoimmunity; 2007 Jul; 40(5):397-402. PubMed ID: 17612902
[TBL] [Abstract][Full Text] [Related]
12. Analysis of peripheral T lymphocyte subpopulations in Graves' disease.
Okabe N; Inoue K; Mori R
J Clin Lab Immunol; 1983 Feb; 10(2):91-5. PubMed ID: 6221106
[TBL] [Abstract][Full Text] [Related]
13. Activated T-lymphocyte subsets in Graves' disease.
N Engl J Med; 1987 Jul; 317(4):247-9. PubMed ID: 3496537
[No Abstract] [Full Text] [Related]
14. [Immunologic reactions in patients with diffuse toxic goiter after mercasolyl treatment].
Epishin AV
Klin Med (Mosk); 1984 Aug; 62(8):90-3. PubMed ID: 6333549
[No Abstract] [Full Text] [Related]
15. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
16. Which anti-thyroid drug?
Cooper DS
Am J Med; 1986 Jun; 80(6):1165-8. PubMed ID: 3755286
[TBL] [Abstract][Full Text] [Related]
17. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
18. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
Molnár I
Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of antithyroid drugs.
Azizi F
Expert Opin Drug Saf; 2006 Jan; 5(1):107-16. PubMed ID: 16370960
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of glucose and glutamine in lymphocytes from Graves' hyperthyroid patients: influence of methimazole treatment.
Werner MC; Costa Rosa LF; Romaldini JH; Curi R
Cell Biochem Funct; 1996 Jun; 14(2):97-104. PubMed ID: 8640958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
